From January 1, 2024 to March 31, 2024, the company has repurchased 12,971,308 shares, representing 2.43% for CNY 147.82 million. With this, the company has completed the repurchase of 20,172,808 shares, representing 3.79% for CNY 243.66 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.09 CNY | +1.20% | +6.77% | -24.87% |
04-24 | ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-24 | ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.87% | 716M | |
-3.39% | 272B | |
-2.76% | 94.47B | |
-2.95% | 43.58B | |
+1.09% | 40.92B | |
+7.25% | 40.44B | |
+6.74% | 39.25B | |
-14.11% | 30.67B | |
-5.11% | 29.32B | |
+14.11% | 25.2B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.